Arq. Bras. Oftalmol. 2021; 84 (6): 10.5935/0004-2749.20210096
Total: 2527
Alexandre Xavier da Costa1; Priscila Cardoso Cristovam1; Joyce Luciana Covre1; Maria Cecilia, Zorat Yu1; Lauren Carmela LaMonica2; José Álvaro Pereira Gomes1; Vagner Rogério dos Santos1
DOI: 10.5935/0004-2749.20210096
1. Department of Ophthalmology and Visual Science, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil
2. Yale School of Public Health, New Haven, CT, USA
Alexandre Xavier Costa
E-mail: [email protected]
Funding: This study received no specific financial support
Disclosure of potential conflicts of interest: José A. P. Gomes: Consultant for Allergan, MSD, Bausch & Lomb/Valeant, Mundipharma, EMS/Legrand, Shire; Lecture board for Alcon, Allergan, Genom, Bausch & Lomb/Valeant, Pfizer, Mundipharma, Grin, Ofta Vision Health; Grants from FAPESP, Capes, Cnpq
How to cite this article:
ABO is licensed under a Creative Commons Attribution-NonComercial 4.0 Internacional.
